Brad Hively
Advisor at Oncology Ventures
About
Former CEO and current Vice Chairman of The Oncology Institute (NASDAQ: TOI), which manages care for 2+ million patients. Led company's 2021 Nasdaq IPO with ~$1 billion market capitalization; prior healthcare investor with TA Associates and General Atlantic. MBA from Stanford.
Colleagues at Oncology Ventures
Ben Freeberg
Founder, Managing Partner at Oncology Ventures
Carolyn Starrett
Advisor at Oncology Ventures
David Cohn
Interim Chief Executive Officer and Chief Medical Officer at Oncology Ventures
Diana Verrilli
General Manager, Navista (a Cardinal Health company) at Oncology Ventures
Emily Melton
Advisor at Oncology Ventures
Harlan Levine
President of Health Innovation and Policy at Oncology Ventures
Jason Shook
Chief Operating Officer at Oncology Ventures
Jay Freeberg
Chief Financial Officer at Oncology Ventures